−5.65USD
−4.00 MUSD
1.91 M
About MyMD Pharmaceuticals, Inc.
Sector
Headquarters
Baltimore
Employees (FY)
6
Website
Founded
1989
FIGI
BBG000RP05T1
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MYMD is 2.86 USD — it has increased by 11.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MyMD Pharmaceuticals, Inc. stocks are traded under the ticker MYMD.
MyMD Pharmaceuticals, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
MYMD stock is 15.91% volatile and has beta coefficient of −0.62. Check out the list of the most volatile stocks — is MyMD Pharmaceuticals, Inc. there?
Yes, you can track MyMD Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
MYMD stock has risen by 43.00% compared to the previous week, the month change is a 9.16% rise, over the last year MyMD Pharmaceuticals, Inc. has showed a 94.39% decrease.
MYMD net income for the last quarter is −2.36 M USD, while the quarter before that showed 4.04 M USD of net income which accounts for −158.46% change. Track more MyMD Pharmaceuticals, Inc. financial stats to get the full picture.
Today MyMD Pharmaceuticals, Inc. has the market capitalization of 5.52 M, it has increased by 22.86% over the last week.
No, MYMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MyMD Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 6.00 employees. See our rating of the largest employees — is MyMD Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MyMD Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MyMD Pharmaceuticals, Inc. stock shows the sell signal. See more of MyMD Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.